ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.75% | 15.71% | 18.99% | 29.21% | 37.20% |
| Total Depreciation and Amortization | 3.95% | 24.88% | 14.63% | 13.08% | 11.43% |
| Total Amortization of Deferred Charges | 0.17% | -1.25% | -3.74% | -5.59% | -7.21% |
| Total Other Non-Cash Items | 14.56% | 5.45% | 27.64% | -10.22% | -17.60% |
| Change in Net Operating Assets | -543.56% | -147.13% | 196.91% | 2,116.57% | -62.63% |
| Cash from Operations | 3.10% | 14.34% | 29.68% | 30.74% | 25.00% |
| Capital Expenditure | -73.91% | -61.29% | -45.33% | -31.77% | 9.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -151.87% | -705.14% | -493.28% | -361.58% | -4.33% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -231.38% | 153.71% | -13.36% | 99.19% | 178.86% |
| Cash from Investing | -172.54% | -161.66% | -135.55% | -114.71% | 25.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 75.00% | 97.01% | 98.20% | 98.53% | 95.21% |
| Issuance of Common Stock | 0.09% | 4.68% | 13.40% | 22.76% | 40.20% |
| Repurchase of Common Stock | -126.93% | -132.18% | -114.96% | -100.27% | -100.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.47% | -11.95% | -11.46% | -10.75% | -10.12% |
| Other Financing Activities | -- | -1,169.59% | -1,169.59% | -1,169.59% | -805.65% |
| Cash from Financing | -66.11% | -8.63% | 22.47% | 38.71% | 45.84% |
| Foreign Exchange rate Adjustments | -76.03% | 523.55% | 301.80% | 2.37% | 1,600.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.25% | 4.75% | 187.18% | 340.71% | 9,174.97% |